TrialClinical genitourinary cancer2018

Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy.

Guru Sonpavde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.